Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study

Saved in:
Bibliographic Details
Published in:Infectious Diseases and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1872109330253217793
collection WordPress RSS
FRELIP Feed Integration
container_title Infectious Diseases and Therapy
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:108215
institution FRELIP
journal_source_facet Infectious Diseases and Therapy
last_indexed 2026-07-30T03:36:25.666Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study
title_alt Efectividad en el Mundo Real de Ceftazidima–Avibactam para Neumonía por Gramnegativos Multirresistentes, Factores de Riesgo Estratificados por Tiempo para Mortalidad a Corto y Largo Plazo, y Costos Hospitalarios: Un Estudio de Cohorte Retrospectivo Multicéntrico
Efficacité réelle du ceftazidime-avibactam pour la pneumonie à Gram négatif multirésistante, facteurs de risque stratifiés dans le temps pour la mortalité à court et long terme, et coûts hospitaliers : une étude de cohorte rétrospective multicentrique
Efetividade no Mundo Real de Ceftazidima–Avibactam para Pneumonia por Gram-Negativos Multirresistentes, Fatores de Risco Estratificados por Tempo para Mortalidade em Curto e Longo Prazo, e Custos Hospitalares: Um Estudo de Coorte Retrospectivo Multicêntrico
title_auth Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study
title_es_txt Efectividad en el Mundo Real de Ceftazidima–Avibactam para Neumonía por Gramnegativos Multirresistentes, Factores de Riesgo Estratificados por Tiempo para Mortalidad a Corto y Largo Plazo, y Costos Hospitalarios: Un Estudio de Cohorte Retrospectivo Multicéntrico
title_fr_txt Efficacité réelle du ceftazidime-avibactam pour la pneumonie à Gram négatif multirésistante, facteurs de risque stratifiés dans le temps pour la mortalité à court et long terme, et coûts hospitaliers : une étude de cohorte rétrospective multicentrique
title_full Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study
title_fullStr Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study
title_full_unstemmed Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study
title_pt_txt Efetividade no Mundo Real de Ceftazidima–Avibactam para Pneumonia por Gram-Negativos Multirresistentes, Fatores de Risco Estratificados por Tempo para Mortalidade em Curto e Longo Prazo, e Custos Hospitalares: Um Estudo de Coorte Retrospectivo Multicêntrico
title_short Real-World Effectiveness of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study
title_sort real-world effectiveness of ceftazidime–avibactam for multidrug-resistant gram-negative pneumonia, time-stratified risk factors for short- and long-term mortality, and inpatient costs: a multicenter retrospective cohort study
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://link.springer.com/article/10.1007/s40121-026-01416-2